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200Objective: Primary biventricular repair for left ventricular outflow tract obstruction and ventricular septal defect
remains challenging. The intermediate-term outcomes and risk factors for mortality remain undefined.
Methods: All patients undergoing primary biventricular repair of left ventricular outflow tract obstruction and
ventricular septal defect from 1995 to 2008 at the C. S. Mott Children’s Hospital, University of Michigan Health
Systems were analyzed.
Results: Thirty-one patients (mean age, 18 days; 20 male) with a median follow-up of 6.7 years (range, 0.3–13.5
years) were identified. The ventricular septal defect was enlarged in 15 patients, and a limited atrial septal defect
was constructed in 16 patients. There were 6 hospital and 2 late deaths. Ten-year patient survival was 72.3%.
Lower body weight (P ¼ .040), complete atrial septal defect closure (P ¼ .026), and longer cardiopulmonary
bypass time (P ¼ .026) were risk factors of hospital mortality. An atrial septal defect was patent in 16 patients
at discharge, 2 of whom required later surgical closure. Relief of recurrent left ventricular outflow tract obstruction
was performed in 1 patient. No patient required pacemaker implantation. Five-year freedom from right ventricle-
to-pulmonary artery conduit replacement was 39.3%. Smaller-sized conduit (P¼ .020) and use of aortic allograft
(P ¼ .048) were risk factors for early failure.
Conclusion: Primary biventricular repair for patients with left ventricular outflow tract obstruction and ventric-
ular septal defect provides good early and intermediate-term outcomes. Maintaining a small atrial septal defect
may improve hospital mortality. Selective ventricular septal defect enlargement and careful construction of the
intraventricular pathway result in a low incidence of recurrent left ventricular outflow tract obstruction, as well
as avoidance of heart block. Maximizing valve diameter and avoiding aortic allografts may lengthen conduit lon-
gevity. (J Thorac Cardiovasc Surg 2011;141:200-6)The majority of patients born with significant left ventricular
outflow tract obstruction (LVOTO) will have associated left
ventricular hypoplasia and will require staged palliation to
a Fontan procedure. However, a subset of these patients
will also have a ventricular septal defect (VSD), providing
an outlet for the left ventricle (LV) and allowing normal ven-
tricular growth. In these patients with 2 adequately sized
ventricles, biventricular repair can be undertaken, but re-
mains challenging. The repair consists of the 2 main compo-
nents. The first is the reconstruction of the aortic arch
incorporating the native proximal pulmonary artery (PA)
in the manner of a modified Norwood procedure. The second
is rerouting the LV output from the VSD to the nativee Division of Pediatric Cardiovascular Surgery, Department of Surgery, Uni-
y of Michigan Medical School, Ann Arbor, Mich.
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The Journal of Thoracic and Cardiovascular Surgpulmonary valve with an intraventricular tunnel and creating
a new connection between the right ventricle (RV) and PA
with a conduit (Rastelli-type operation).1
There are 2 surgical strategies that can be used to achieve
this goal. One approach is the 2-stage repair with an initial
Norwood procedure, followed by a Rastelli-type biventricu-
lar repair. This approach was the first method used to treat
these patients.2-4 More recently, primary repair, which
avoids the interstage mortality, volume overload, and
cyanosis caused by shunt-dependent physiology, has be-
come the preferred method of repair at many centers.5–11
In 1999, we compared the early clinical outcomes of
primary repair versus staged repair12 and demonstrated
that the survival of those undergoing primary repair was
comparable to the survival of those undergoing 2-stage re-
pair. Since that time, several other reports have also shown
the safety and effectiveness of this strategy.13,14
Although hospital survival and short-term outcomes are
acceptable for primary repair, risk factors for mortality and
longer-term results remain unknown. One late concern is
the fate of the reconstructed LVOT. Primary repair requires
the creation of an intraventricular pathway from the VSD
to the native pulmonary valve (Rastelli-type procedure) toery c January 2011
Abbreviations and Acronyms
ASD ¼ atrial septal defect
LV ¼ left ventricle
LVOT ¼ left ventricular outflow tract
LVOTO ¼ left ventricular outflow tract
obstruction
MV ¼ mitral valve
PA ¼ pulmonary artery
RV ¼ right ventricle
VSD ¼ ventricular septal defect
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term studies of patients with transposition of the great
arteries undergoing the Rastelli procedure have shown an
incidence of recurrent LVOTO.15 The other concern is the
durability of an RV-to-PA conduit. Although several mate-
rials and technical modifications have been described, an
ideal conduit for small-sized patients remains elusive. All
patients undergoing placement of an RV-to-PA conduit in
the neonatal period will ultimately require replacement.
This study analyzed the risk factors for mortality and
assessed the intermediate-term outcomes of primary repair.MATERIALS AND METHODS
Patients
Between 1995 and 2008, 31 patients with LVOTO and VSD underwent
primary biventricular repair at C. S. Mott Children’s Hospital, University of
Michigan Health System (Table 1). Ten of these patients, who had under-
gone this procedure before 1999, were included in the earlier report.12 Since
then, we have used primary biventricular repair as the preferred strategy, and
the latter 21 consecutive patients of this group underwent this approach.
This study was approved by the University of Michigan Medical School
Institutional Review Board for Human Subject Research.
Operative Techniques
Therewere 3mainmethods of aortic arch reconstruction. Twelve patients
underwent a Norwood-type arch reconstruction as previously described
(Figure 1, A).16 Early in the experience, 12 patients with interrupted aortic
arch type B underwent reverse-oriented direct anastomosis between the
ascending and the descending aorta (Figure 1, B). For this technique, the
ascending aorta was transected just above the sinotubular junction and the
descending aorta was transected just distal to the ductus arteriosus. The
back wall of the distal ascending aorta was then anastomosed directly to
the back wall of the descending aorta, leaving an opening in the anastomosis
inferiorly. The proximal ascending aortawas connected to the proximalmain
PA in an end-to-side or a side-by-side fashion. Next, a direct anastomosis
between the proximal main PA and the reconstructed transverse arch was
performed. The remaining 6 patients underwent direct anastomosis of the
proximal main PA and the distal ascending aorta (Figure 1,C). For this tech-
nique, both the main PA and ascending aorta were divided just distal to the
sinotubular junction. The distal ascending aorta and arch were augmented as
necessary with cryopreserved pulmonary allograft. The distal ascending
aorta was then anastomosed directly to the proximal main PA. The proximal
end of the ascending aorta was connected to the main pulmonary trunk in an
end-to side fashion. For both of the latter 2 techniques, a LecomptemaneuverThe Journal of Thoracic and Cawas performed to facilitate reconstruction of the aortic arch and RV-to-PA
conduit placement.17
Patients underwent the arch reconstruction with deep hypothermic circu-
latory arrest or regional cerebral perfusion, on the basis of a randomized trial
ongoing during part of the experience. Standard methods were used for both
techniques as previously described.18
After the arch reconstruction, a right ventriculotomy was performed.
Through the right ventriculotomy, the VSD was closed with a polytetra-
fluoroethylene patch constructed to form an intraventricular pathway from
the LV to the pulmonary valve (neoaortic valve) as in a typical Rastelli
procedure. The VSD was enlarged anterosuperiorly at the discretion of
the operating surgeon according to the intraoperative appearance. The atrial
septal defect (ASD) was also closed or partially closed at the discretion of
the operating surgeon. Delayed sternal closure was used in all patients.
Data Collection and Statistical Analysis
Preoperative and postoperative data were collected from the patients’
medical records. The intermediate-term follow-up data were collected
from the outpatient caregivers. Data are expressed as mean  standard de-
viation or as medians (range) as appropriate and were analyzed with Stat
View (SAS Institute Inc, Cary, NC). Independent risk factors associated
with hospital mortality were sought using logistic regression. Risk factors
for hospital mortality identified by univariate analysis were selected for
the multivariate analysis if there was no sizable direct correlation between
these factors. Actuarial survival and freedom from RV-PA conduit replace-
ment were estimated by the Kaplan–Meier method. Both the Cox propor-
tional hazard regression analysis and log-rank test were applied to
analyze the risk of RV-PA conduit replacement because of the differing
follow-up periods.RESULTS
Patients
Patient demographics are summarized in Table 1. The me-
dian follow-up period for all hospital survivors was 6.7 years
(range, 0.3–13.5 years).Anatomic Features
Preoperative diagnosis was based on transthoracic echo-
cardiography. The aortic valve was atretic in 6 patients.
The remaining 25 patients had aortic annulus hypoplasia
(4.2  0.6 mm,7.1  2.3 Z), 13 of whom had a bicuspid
aortic valve. All patients had LVOTO with an apex-
forming LV. Transmitral valve mean inflow gradient of all
patients was less than 4 mm Hg. The associated major ex-
tracardiac and cardiovascular malformations are listed in
Table 1. All patients had both a patent ductus arteriosus
and an ASD or patent foramen ovale. One patient with Taus-
sig–Bing anomaly and aortic atresia had undergone bilateral
PA banding before transfer to the University of Michigan
Medical School. No patient underwent balloon aortic valvu-
loplasty before operation.Operative Techniques
Mean cardiopulmonary bypass time, aortic crossclamp
time, and regional cerebral perfusion/deep hypothermic
circulatory arrest times are listed in Table 2. Regional
cerebral perfusion was used in 8 patients, and deeprdiovascular Surgery c Volume 141, Number 1 201
TABLE 1. Patient characteristics
Patient population (n ¼ 31)
Patient characteristics
Male:female (n) 20: 11
Age at operation (d, mean  SD) 18.2  20.4
Body weight at operation (kg, mean  SD) 3.3  0.6
Body surface area at operation (m2, mean  SD) 0.21  0.02
Gestational age<38 wk (n) 3
Major extracardiac abnormality (n) 15
DiGeorge syndrome 13
CHARGE association 2
Cardiac anatomy (n)
Aortic valve
Atresia 6
Hypoplastic 25
Aortic valve morphology
Bicuspid 13
Tricuspid 4
Associated cardiac anomalies
Interrupted aortic arch 23
Type A 1
Type B 20
Type C 2
Coarctation of the aorta with hypoplastic aortic arch 4
Double outlet right ventricle with aortic atresia 1
Aortopulmonary window 1
Aberrant right subclavian artery 8
Anomalous coronary artery 5
Left superior vena cava 3
Right aortic arch 1
Dextrocardia 1
SD, Standard deviation.
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23 patients.
The VSD was enlarged in 15 patients to ensure an unob-
structed left ventricular outflow tract (LVOT) pathway. For
reconstruction of RV-to-PA continuity, various types of
conduit were inserted, as summarized in Table 2. The
mean conduit diameter was 11  1.6 (range, 8–14) mm in
16 of 31 patients (52%). An atrial level shunt (patent fora-
men ovale or partially closed ASD) was left at the time ofFIGURE 1. Three types of operative methods for aortic arch reconstruction. A
Direct anastomosis.
202 The Journal of Thoracic and Cardiovascular Surgoperation in 16 patients (52%) at the discretion of the oper-
ating surgeon.
Early Outcome and Mortality In Hospital
Hospital survival was 80.6% (25/31 patients). The mean
durations of postoperative ventilator support, intensive care
unit stay, and hospital stay of all hospital survivors were
11.4  8.7 days, 14.7  9.6 days, and 26.3  12.8 days,
respectively.
Postoperative complications were low cardiac output
syndrome requiring extracorporeal membrane oxygenation
support in 3 patients (all hospital mortalities), mediastinitis
in 2 patients (including 1 hospital mortality), arrhythmias
in 3 patients (including 1 hospital mortality), prolonged
ventilator support in 3 patients, chylothorax in 2 patients,
thromboembolic event in 2 patients, graft-versus-host
disease in 1 patient (hospital mortality), seizure in 1 patient,
necrotizing enterocolitis in 1 patient, and hemi-diaphragm
paralysis in 1 patient.
Echocardiography at discharge demonstrated a patent
atrial level shunt in 16 patients (left to right in 8 patients,
right to left in 1 patient, and bidirectional in 7 patients)
with a mean percutaneous oxygen saturation on room air
at discharge of 94.3%  2.9% (range, 90%–99%). Other
echocardiographic findings at discharge were RV-to-PA
conduit insufficiency more than mild in 10 patients (40%),
branch PA stenosis in 6 patients (24%), and tricuspid valve
insufficiency more than mild in 5 patients (20%). All pa-
tients with branch PA stenosis had undergone a Lecompte
maneuver. No patients demonstrated an RV-to-PA conduit
gradient of more than 20 mm Hg, more than trivial ventric-
ular level shunting by Doppler echocardiography, a pressure
gradient across the LVOT, neoaortic valve insufficiency of
more than mild, heart block requiring pacemaker implanta-
tion, or depressed LV systolic function.
Univariate analysis identified that body weight and body
surface area at operation, complete ASD closure, and cardio-
pulmonary bypass time were significant risk factors of hos-
pital mortality (Table 3). Multivariate analysis identified
none of these variants as independent risk factors., Norwood-type reconstruction. B, Reverse-oriented direct anastomosis. C,
ery c January 2011
TABLE 2. Perioperative data
Perioperative data (n ¼ 31)
Operative data (mean  SD)
Cardiopulmonary bypass time 131  36
Aortic crossclamp time 79  13
Regional cerebral perfusion time (n ¼ 8) 40  4
Circulatory arrest time (n ¼ 23) 41  24
Operative method (n)
Aortic arch reconstruction
Norwood-type 12
Reversed-oriented direct anastomosis 12
Direct anastomosis 6
Interposition graft 1
Right ventricle-to-pulmonary artery
conduit materials
Cryopreserved pulmonary allograft 14
Cryopreserved aortic allograft 8
Contegra pulmonary valved conduit* 4
Shelhigh pulmonic valve conduity 3
Hancock valved conduitz 2
Lecompte maneuver 17
ASD completely closed 15
Subclavian artery division 7
*Medtronic Inc, Minneapolis, Minn. yShelhigh Inc, Union, NJ. zMedtronic, Inc.
SD, Standard deviation; ASD, atrial septal defect.
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Intermediate-term follow-up data collection was complete
in 22 of 25 hospital survivors (88%) (Table 4). Patient sur-
vival at 10 years was 72.3%.
Intervention for branch PA stenosis was performed in 5 pa-
tients (25%). All of the patients requiring reintervention on
the branch PAs underwent a Lecompte maneuver at the pri-
mary operation. Residual aortic arch obstruction of more
than 30mmHgdeveloped in 3 patients. These patients under-
went patch augmentation or balloon angioplasty at 5.8, 6.3,TABLE 3. Risk factor analysis for hospital mortality
Variable Expired (n ¼ 6) Survived (n ¼ 25) P
BW at operation (kg) 2.70  0.51 3.45  .46 .0
Complete ASD closure (n) 6/6 9/25 .0
CPB time (min) 159  40 121  32 .0
AVD (Z) 5.8  2.2 7.4  2.3 .1
Lecompte maneuver (n) 2/6 15/25 .2
Male (n) 5/6 15/25 0.2
AXC time (min) 83.8  6.6 78.1  13.8 .3
Age at operation (d) 24.8  22.7 16.6  20.0 .3
AVD (mm) 4.4  0.7 4.1  0.6 .4
Conduit size (mm) 10.7  1.4 11.2  1.7 .5
Norwood arch
reconstruction (n)
3/6 9/25 .5
Coronary anomaly (n) 1/6 6/25 .7
VSD enlargement 2/6 15/25 .9
CI, Confidence interval; BW, body weight; BSA, body surface area; ASD, atrial septal defect
VSD, ventricular septal defect.
The Journal of Thoracic and Caand 7.5 months after the primary operation, which resulted
in successful relief of the pressure gradient. Postoperative re-
lief of recurrent LVOTO was required in only 1 patient. No
patient required permanent pacemaker implantation.
Actuarial freedom from RV-PA conduit replacement at 1,
3, and 5 years after operation was 87.1%, 54.2%, and
39.3%, respectively (Figure 2, A). Cox’s proportional
hazards models identified that smaller conduit size were
significant risk factors of early conduit failure (P ¼ .020)
(Figure 2, B). Log-rank test identified that aortic allograft
failed earlier than pulmonary allograft (P ¼ .048)
(Figure 2, C).DISCUSSION
This study of the early and intermediate-term clinical
outcomes of primary biventricular repair for 31 consecutive
patients with VSD and LVOTO reveals that primary biven-
tricular repair can be performed with good survival. Signif-
icant risk factors for hospital mortality on univariate analysis
were lower body weight at operation, complete closure of
atrial level shunt, and longer cardiopulmonary bypass
time. Most likely because of sample size, none of these vari-
ables could be identified as independent risk factors on mul-
tivariable logistic analysis.
Our strategy of management for LVOTO and VSD with
an adequately sized LV is as follows. If a patient has an aor-
tic valve of good size and the obstruction is subvalvar, the
VSD is closed primarily and a septal myectomy-myotomy
is performed to relieve the subaortic stenosis. If the aortic
valve is too small to function as the systemic semilunar
valve, the native pulmonary valve is used as the neoaortic
valve by 1 of 2 methods. In the presence of an adequately
sized VSD, we prefer a Rastelli-type operation. This general
preference is also because there is often extension of theUnivariate Multivariate
Odds ratio 95% CI P Odds ratio 95% CI
40 0.12 0.0–0.9 .057 0.28 0.04–1.88
26 13.1 1.4–126.3 .997 4.6 0.36–60.0
26 1.003 1.0–1.6 >.238 1.00 0.99–1.06
80
53
99
37
82
38
26
43
11
33
; CPB, cardiopulmonary bypass; AVD, aortic valve diameter; AXC, aortic crossclamp;
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TABLE 4. Surgical and catheter-based interventions
Procedure n (%)
RV-to-PA conduit replacement 13 (59.1)
Repair of branch PA stenosis 5 (22.7)
Repair of VSD patch leak 3 (13.6)
Patch augmentation/balloon angioplasty
for arch obstruction
3 (13.6)
Residual ASD closure 2 (9.1)
Repair of recurrent LVOTO 1 (4.5)
Patch exclusion of LVOT aneurysm 1 (4.5)
RV,Right ventricle; PA, pulmonary artery; VSD, ventricular septal defect; LVOTO, left
ventricular outflow tract obstruction; ASD, atrial septal defect; LVOT, left ventricular
outflow tract.
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DVSD to the outlet, complicating the harvesting of the pulmo-
nary autograft with a circumferential rim of muscle. In
contrast, if the VSD is small or not present, we use
a Ross–Konno procedure and VSD closure. During the
study period, no patients with LVOTO and VSD underwent
a Ross–Konno procedure and VSD closure during the neo-
natal or early infant period at the University of Michigan
Medical School. This is perhaps not surprising because%
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204 The Journal of Thoracic and Cardiovascular Surgmost patients with significant LVOTO and a restrictive or
absent VSD will also develop LV hypoplasia and not be
a candidate for biventricular repair.
It is difficult to address the absolute subaortic diameter
that separates critical and non-critical LVOTO, and this
study was not designed to answer this question. In clinical
practice, we do not use any formula or absolute or normal-
ized measurements to definitively determine which patients
have an inadequate LVOT. These decisions were made on
the basis of the experience of the operating surgeon and
the other members of the management team.
Of these risk factors, management of the ASD can be eas-
ily altered at the time of operation. For this operation, several
surgical factors may affect the RV function in the early post-
operative phase. First, an anterior right ventricular incision is
required for better inspection to perform intraventricular re-
routing and to set the RV-PA conduit as large as possible.
Second, creation of the intraventricular pathway without
LVOTO tends to reduce the effective right ventricular
volume. Also, the use of cardiopulmonary bypass time can
cause acute myocardial dysfunction and increase pulmonary
vascular resistance postoperatively. These negative right-%
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Dsided hemodynamic effects of the operation may be miti-
gated by the presence of an atrial level shunt. Indeed, most
of the atrial shunts were patent at discharge, half of them
demonstrating bidirectional or right-to-left shunting. In ad-
dition, in the setting of the development of late branch PA
or RV-to-PA conduit stenosis or conduit insufficiency, the
ability to shunt right to left may be protective. Those subjects
who were discharged with left-to-right shunting may have
represented patients with greater degrees of mitral valve
(MV) hypoplasia, decreased LV compliance, or the normal
physiologically higher left atrial pressure relative to right
atrial pressure. Although the closure of a residual atrial level
shunt was ultimately required in 2 of 16 patients, the remain-
ing patients showed no shunting at late follow-up.
In our cohort, only 1 subject had an MV inflow gradient,
measured at 4 mm Hg by Doppler echocardiography. This
subject had only a small patent foramen ovale, making the
interpretation of the gradient more straightforward. How-
ever, determining the adequacy of the MV on the basis of
the inflow gradient can be problematic in the face of a nonre-
strictive or mildly restrictive atrial level shunt, as was the
case in many of the subjects in this study. In these cases,
we rely on the diameter and z-values of the MV annulus,
as well as the morphology of the valve leaflets (eg, good ex-
cursion vs limited opening, thickened leaflets vs thin, mobile
leaflets) and papillary muscles (single, dominant, closely
spaced, or normal) to make a clinically based decision, along
with the inflow gradients. All of the patients in this study
were deemed to have an adequate MV and reasonable
z-values (range, 0.8 to 2.3). In addition, we tolerate
some degree of potential MV hypoplasia, because there is
evidence that the MV, as well as the LV, will demonstrate
good potential for growth after repair.19
Our series also demonstrated that postoperative LVOTO
was rare. Kreutzer and colleagues15 reported that freedom
from reintervention for LVOTO was 88% at 5 years for the
Rastelli procedure for dextro-transposition of the great ar-
teries with VSD and LVOTO. They also noted that time to
LVOTO reintervention was shorter for patients undergoing
a Rastelli repair at less than 1 year of age. Postoperative
LVOTO occurred in only 1 patient (4%) in the current study.
It is likely that a low threshold for VSD enlargement, per-
formed in half of all patients, and careful construction of the
LVOT baffle contributed to the low occurrence of LVOTO.
Although enlargement of the VSD may be effective in
helping to prevent late LVOTO, there is risk of damage to
the conduction system or injury to the septal perforating ar-
teries.20 However, in this series, no patients required postop-
erative permanent pacemaker implantation, and all patients
were discharged with normal ventricular function. Enlarge-
ment of the VSD in a superior and anterior direction avoids
aortic valve conduction injury because the connecting bun-
dle in this anatomic group is theoretically located posteroin-
feriorly.The Journal of Thoracic and CaIn our previous study, we frequently used the Lecompte
maneuver to facilitate the posterior reconstruction of the
aorta to decrease the distance for the RV-to-PA conduit
from the anteriorly located RV to the posterior pulmonary
bifurcatio, and to facilitate later RV-to-PA conduit replace-
ments.12 However, our ongoing experience, as presented
in this article, revealed a higher incidence of branch PA
stenosis with this maneuver. In addition, our technique has
evolved to primarily using a Norwood-type repair technique
for the aortic reconstruction. This technique, as opposed to
the others described, tends to create a larger, more anteriorly
situated neoaorta. This arrangement is also less favorable for
the Lecompte maneuver. Our current preference is to per-
form the RV-to-PA conduit in the standard fashion more
commonly associated with the typical Rastelli procedure.
The problem of conduit durability remains unsolved for
all pediatric patients because of the lack of growth potential
in the currently available options. However, some conduits
may perform better than others. In the current study, aortic
allografts and smaller-sized conduit were found to be infe-
rior, as previously reported by others.21-23 Pulmonary
allografts were preferentially used during the majority of
the time interval of this study, including the use of
bicuspidized grafts as necessary when an appropriately
sized allograft was not available.24 Although the long-term
durability is still unknown, the Contegra (Medtronic Inc,
Minneapolis, MN) bovine jugular vein conduit, which is
readily available in a variety of pediatric sizes, may also be
a good alternative to pulmonary allograft.25
CONCLUSIONS
Our analysis of the early and intermediate-term clinical
outcomes of primary biventricular repair for patients with
LVOTO with VSD demonstrates good results. Maintaining
a small degree of atrial level shunting may improve hospital
mortality. Selected VSD enlargement and careful construc-
tion of the intraventricular pathway result in a low incidence
of recurrent LVOTO, as well as avoidance of heart block.
Although all RV-PA conduits will eventually require re-
placement in this young cohort of patients, maximizing
valve diameter and avoiding the use of aortic allografts
may lengthen conduit longevity.
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